Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128719) titled 'The effect of oxelidine on intraoperative hypoxemia in obese patients undergoing hysteroscopic surgery: A randomized, controlled, double-blind, non-inferiority trial' on July 24.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Xiangyang Central Hospital
Condition:
hyoxemia
Intervention:
Sufentanil group:intravenous injection Sufentanil (0.1 micrograms per kilogram)
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2025-09-30
Target Sample Size: Sufentanil group:90;Oliceridine group:90;
Countries of Recruitment:
China
To know more, visit https://www.chictr...